Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Sonoma Biotherapeutics
400 E. Jamie Ct, Suite 202
South San Francisco, CA 94080
https://www.sonomabio.com/

Sonoma Biotherapeutics is a privately held company leading the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

Key Contact
NameTitleE-Mail
Jeffrey Bluestone, PhDFounder, President & CEOjbluestone@sonomabio.com


Funding Events
DateAmountTypeInvestors
02/06/20$40,000,000Series A 8VC
ARCH Venture Partners
Lyell Immunopharma
Milky Way Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.